New hope for rare dementia: drug trial targets language loss
Disease control
Not yet recruiting
This study tests a new drug called NS101 in 15 people with a rare type of dementia that mainly affects language (semantic variant primary progressive aphasia). The goal is to see if the drug is safe and how it works in the body. Participants will receive either the drug or a plac…
Phase: PHASE2 • Sponsor: Hee-Jin Kim • Aim: Disease control
Last updated May 17, 2026 10:39 UTC